Table 2.
Group differences associated with conversion in both groups
Predictors of conversion | No conversion n = 74 | Conversion n = 21 | p value (p < 0.05) |
---|---|---|---|
Age > 65 | 53 (70.6%) | 13 (61.9%) | 0.48 |
BMI > 25 | 39 (52.0%) | 11 (52.4%) | 0.98 |
ASA (IQR) | 2 (1–3) | 2 (1–2) | 0.20 |
Tumor size > 50 mm | 41 (54.6%) | 9 (42.9%) | 0.38 |
Central tumor | 27 (36.4%) | 14 (66.7%) | 0.046 |
Pneumonectomy | 8 (10.8%) | 9 (42.9%) | < 0.001 |
Lobectomy | 57 (77.0%) | 11 (52.4%) | 0.025 |
General invasion | 29 (38.6) | 15 (71.4%) | 0.009 |
Pleural invasion | 20 (26.7%) | 6 (28.6%) | 0.47 |
Vascular invasion | 5 (6.7%) | 7 (33.3%) | 0.001 |
Left upper lobe | 14 (18.7%) | 12 (57.1%) | < 0.001 |
Squamous cell (histology) | 25 (33.3%) | 17 (81.0%) | < 0.001 |
Induction therapy | 5 (6.8%) | 5 (23.8%) | 0.025 |
Additional Surgery | 3 (4.1%) | 5 (23.8%) | 0.004 |
Statistically significant values (p < 0.05) in bold